BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
3,379,268
Share change
+432,745
Total reported value
$147,131,495
Price per share
$43.54
Number of holders
83
Value change
+$16,936,116
Number of buys
50
Number of sells
29

Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q3 2015

As of 30 Sep 2015, BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,379,268 shares. The largest 10 holders included ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Allianz Asset Management AG, VANGUARD GROUP INC, RK Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, Elk Creek Partners, LLC, and WELLS FARGO & COMPANY/MN. This page lists 83 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.